Opportunity Information: Apply for PAR 08 017

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIDCD Research Grants for Translating Basic Research into Clinical Tools for Human Health (R01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173 Research Related to Deafness and Communication Disorders.
  • This funding opportunity was created on Dec 5, 2008 and posted on Oct 26, 2007.
  • Applicants must submit their applications by Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification).
  • Foreign institutions are eligible to apply.
Apply for PAR 08 017

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The NIDCD Research Grants for Translating Basic Research into Clinical Tools for Human Health (R01) opportunity (Funding Opportunity Number PAR-08-017) is an NIH grant program designed to move solid basic research discoveries toward practical clinical tools that improve human health in the National Institute on Deafness and Other Communication Disorders mission areas. These areas include hearing, balance, smell, taste, voice, speech, and language. The central idea is to create a clearer pathway for researchers who generate fundamental scientific insights to work directly with clinicians and clinical scientists so those insights can be shaped into tools that make a difference in real-world healthcare, particularly tools that support the diagnosis, treatment, or prevention of communication disorders.

A major emphasis of this program is genuine translational work, meaning the project should be past the stage of generating basic knowledge and should be focused on converting prior findings into something clinically usable. Examples of what "clinical tools" can imply in this context include new or improved diagnostic approaches, clinically relevant assays, assessment methods, therapeutic strategies, devices, or other interventions that are anchored in earlier basic research results and are being advanced toward clinical application. The FOA explicitly encourages team science and partnership models that make translation more likely to succeed, including multi-institution collaborations, multidisciplinary teams, and academic-industry collaborations. In practice, this signals that applications bringing together complementary expertise (for example, a basic auditory neuroscientist working with an otolaryngologist, an engineer, and a biostatistician, or a speech-language researcher partnering with a technology developer) are especially aligned with the intent of the announcement.

At the same time, the announcement draws clear boundaries around what it is not meant to support. It is not intended for outcomes studies, for simply extending ongoing clinical research projects, for efforts aimed mainly at optimizing or fine-tuning existing clinical protocols, or for pre-translational studies that are still focused on foundational discovery without a concrete path toward a clinical tool. In other words, a strong application should be positioned in the middle ground where the basic science foundation already exists and the proposed work is specifically about building, adapting, validating, or otherwise advancing a clinical tool that derives from that foundation.

In terms of funding mechanism, this FOA uses the NIH Research Project Grant (R01) format, which generally supports more mature, hypothesis-driven or milestone-driven projects with a substantial scope of work. The NIDCD also ran a parallel opportunity with the same scientific scope under the R21 mechanism (PAR-08-018), which typically supports earlier-stage exploratory or developmental work. Applicants would choose between the R01 and R21 based on the maturity of the translational concept, the amount of preliminary data, and the scale of the proposed research plan.

The funding details emphasize flexibility rather than fixed award sizes. There were no set-aside funds reserved exclusively for this initiative, and awards depended on the availability of NIDCD funds. Applications were to be reviewed by an institute special review group, and the program used special receipt dates across five submission cycles. Because projects could differ widely in scope, the NIH expected both the size and the duration of awards to vary from one project to another. Ultimately, how many grants were made, and at what budget levels, depended on the quality of the applications received as well as their proposed duration and costs.

Eligibility for this opportunity was broad and included many common NIH applicant types: public and private institutions of higher education, nonprofits (including 501(c)(3) and certain non-501(c)(3) organizations), for-profit organizations (including small businesses), and other eligible entities as described in the full announcement. Importantly, foreign institutions were also eligible to apply, which opens the door for international research organizations to lead projects or participate as collaborators when appropriate. The opportunity was categorized under CFDA 93.173 (Research Related to Deafness and Communication Disorders), did not require cost sharing or matching, and was posted in late 2007 with multiple receipt dates and an archived date of November 13, 2010.

Overall, PAR-08-017 was built for teams that already have a credible basic science foundation and are ready to do the work of translation: taking what is known from laboratory or fundamental studies and deliberately engineering it into a clinically meaningful tool that can improve the way communication disorders are detected, treated, or prevented.

FAQs: NIDCD Research Grants for Translating Basic Research into Clinical Tools for Human Health (R01) - PAR-08-017

What is PAR-08-017?

PAR-08-017 is a Funding Opportunity Announcement (FOA) from the National Institutes of Health (NIH), specifically through the National Institute on Deafness and Other Communication Disorders (NIDCD). It supports Research Project Grants (R01) aimed at translating solid basic research findings into practical clinical tools that improve human health in NIDCD mission areas.

What is the main goal of this grant program?

The goal is to create a clearer pathway from basic science discoveries to clinically usable tools. Projects are expected to take prior foundational findings and deliberately advance them toward real-world healthcare impact, especially tools that support diagnosis, treatment, or prevention of communication disorders.

Which scientific and clinical areas does the opportunity cover?

The FOA is aligned with NIDCD mission areas, including hearing, balance, smell, taste, voice, speech, and language.

What does "translating basic research into clinical tools" mean in this FOA?

In this program, translational work means the project is past the stage of generating basic knowledge and is focused on converting existing basic research findings into something clinically usable. The emphasis is on moving from established discovery to tool-building, adaptation, validation, or advancement toward clinical application.

What kinds of "clinical tools" are envisioned?

The FOA uses "clinical tools" broadly. Examples include new or improved diagnostic approaches, clinically relevant assays, assessment methods, therapeutic strategies, devices, or other interventions that are anchored in earlier basic research results and are being advanced toward clinical use.

What types of project teams are encouraged?

The FOA explicitly encourages team science and partnership models that increase the likelihood of successful translation. This includes multi-institution collaborations, multidisciplinary teams, and academic-industry collaborations, especially where complementary expertise is brought together (for example, basic researchers working directly with clinicians and clinical scientists).

Is collaboration required, or just encouraged?

Based on the information provided, collaboration is strongly encouraged as a way to improve translational success, particularly partnerships that connect basic research expertise with clinical and/or applied development expertise.

What is this FOA not intended to support?

PAR-08-017 is not intended to support outcomes studies, projects that simply extend ongoing clinical research, efforts primarily aimed at optimizing or fine-tuning existing clinical protocols, or pre-translational studies that are still focused on foundational discovery without a concrete path to a clinical tool.

How can applicants tell if their project is a good fit?

A strong fit is typically in the "middle ground" described in the FOA: the basic science foundation already exists, and the proposed research is specifically aimed at advancing a clinically meaningful tool derived from that foundation (for example, building, adapting, or validating a tool for clinical application).

What funding mechanism does PAR-08-017 use?

This FOA uses the NIH Research Project Grant (R01) mechanism, which generally supports more mature projects with substantial scope, often hypothesis-driven or milestone-driven.

Is there a related R21 opportunity mentioned?

Yes. NIDCD ran a parallel opportunity with the same scientific scope under the R21 mechanism (PAR-08-018). The R21 is described as typically supporting earlier-stage exploratory or developmental work.

How should an applicant choose between the R01 (PAR-08-017) and the R21 (PAR-08-018)?

The choice depends on the maturity of the translational concept, the amount of preliminary data available, and the scale of the proposed research plan. The R01 is positioned for more mature, substantial projects, while the R21 is positioned for earlier-stage exploratory/developmental efforts.

Are there set-aside funds reserved for this initiative?

No. The funding details indicate there were no set-aside funds reserved exclusively for this initiative, and awards depended on the availability of NIDCD funds.

How are applications reviewed?

Applications were to be reviewed by an institute special review group, according to the information provided.

Were there standard NIH deadlines or special receipt dates?

The FOA used special receipt dates across five submission cycles, rather than relying only on standard receipt dates.

Are award sizes and project durations fixed?

No. The FOA emphasized flexibility rather than fixed award sizes. Because projects could vary widely in scope, NIH expected both the size and duration of awards to vary across projects.

What determines how many awards are made and at what budget levels?

According to the details provided, the number of grants and budget levels depended on the availability of NIDCD funds, the quality of applications received, and the proposed duration and costs of the projects.

Who is eligible to apply?

Eligibility was broad and included public and private institutions of higher education, nonprofits (including 501(c)(3) and certain non-501(c)(3) organizations), for-profit organizations (including small businesses), and other eligible entities as described in the full announcement.

Are foreign institutions eligible?

Yes. Foreign institutions were eligible to apply, which supports international organizations leading projects or participating as collaborators when appropriate.

Is cost sharing or matching required?

No. The opportunity did not require cost sharing or matching.

What is the CFDA number associated with this opportunity?

The opportunity was categorized under CFDA 93.173, titled Research Related to Deafness and Communication Disorders.

When was this opportunity posted, and what is its archived date?

It was posted in late 2007, had multiple receipt dates, and had an archived date of November 13, 2010.

What is the simplest way to summarize what NIDCD wanted to fund under PAR-08-017?

Teams with credible basic science foundations that are ready to do real translation: taking established findings from laboratory or fundamental studies and deliberately engineering them into clinically meaningful tools that improve how communication disorders are detected, treated, or prevented.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: NIDCD Research Grants for Translating Basic Research into Clinical Tools for Human Health (R21)

Previous opportunity: Angiogenesis in the Nervous System in Health and Disease (R21)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 08 017

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 08 017) also looked into and applied for these:

Funding Opportunity
NIDCD Research Grants for Translating Basic Research into Clinical Tools for Human Health (R21) Apply for PAR 08 018

Funding Number: PAR 08 018
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Assay Development for High Throughput Molecular Screening (R21) Apply for PAR 08 024

Funding Number: PAR 08 024
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Support of Competitive Research (SCORE) Research Advancement Award (SC1) Apply for PAR 08 026

Funding Number: PAR 08 026
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Support of Competitive Research (SCORE) Pilot Project Award (SC2) Apply for PAR 08 027

Funding Number: PAR 08 027
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
Support of Competitive Research (SCORE) Research Continuance Award (SC3) Apply for PAR 08 028

Funding Number: PAR 08 028
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Solicitation of Assays for High Throughput Screening (HTS) in the Molecular Libraries Probe Production Centers Network (MLPCN) (R03) Apply for PAR 08 035

Funding Number: PAR 08 035
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Reducing Mental Illness Stigma and Discrimination (Collaborative R01) Apply for PAR 08 040

Funding Number: PAR 08 040
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIMH Research Education Grants (R25) Apply for PAR 08 079

Funding Number: PAR 08 079
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alcohol Research Education Project Grants (R25) Apply for PAR 08 082

Funding Number: PAR 08 082
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Health Behavior Change in People with Mental Disorders (R01) Apply for PA 08 089

Funding Number: PA 08 089
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Metagenomic Analyses of the Oral Microbiome (R01) Apply for PA 08 090

Funding Number: PA 08 090
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Approaches to Study Polymicrobial Diseases (R01) Apply for PA 08 091

Funding Number: PA 08 091
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Approaches To Study Polymicrobial Diseases (R21) Apply for PA 08 092

Funding Number: PA 08 092
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
CAM Practitioner Research Education Project Grant Partnership Competitive Renewal (R25) Apply for PAR 08 095

Funding Number: PAR 08 095
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Family Planning Service Delivery Improvement Research (R01) Apply for PAR 08 999

Funding Number: PAR 08 999
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Genome Wide Association Analysis of Existing Data Sets for Arthritis and Musculoskeletal and Skin Diseases (R01) Apply for PAR 08 123

Funding Number: PAR 08 123
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mouse Models Containing Human Alleles Novel Tools to Study Brain Function (R21/R33) Apply for PAR 08 158

Funding Number: PAR 08 158
Agency: National Institutes of Health
Category: Health
Funding Amount: $150,000
Adverse Metabolic Side Effects of Second Generation Psychotropic Medications Leading to Obesity and Increased Diabetes Risk (R01) Apply for PAR 08 160

Funding Number: PAR 08 160
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mechanisms of Alcohol Induced Tissue Injury (R01) Apply for PA 08 164

Funding Number: PA 08 164
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Secondary Analysis of Existing Alcohol Epidemiology Data (R01) Apply for PA 08 167

Funding Number: PA 08 167
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 08 017", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.